Characterized by their hallmark cytokines, IL-10 and TGF-β, which can effectively suppress tumor-specific T cell activation, Tregs are attracted to the local tumor environment by soluble mediators, such as CCL22 or CCL2 produced by glioblastoma cells (17–19). This evidence concerns the gene CCL22 and neoplasm.